TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/19 16:15 | 8/13/19 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yocca Frank | CT | O | Chief Sc | P | 57 | 8.67 | 0 | 7 | 354 | 8 | D | ||||||||||||||
12/6/18 06:04 | 12/3/18 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yocca Frank | CT | O | Chief Sc | P.m | 5 | 5.21 | 0 | 1 | 95 | 2 | D | ||||||||||||||
11/30/18 17:35 | 11/30/18 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yocca Frank | CT | O | Chief Sc | P | 2 | 5.20 | 0 | 0 | 90 | 1 | D | ||||||||||||||
11/30/18 14:31 | 11/29/18 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yocca Frank | CT | O | Chief Sc | P | 3 | 5.02 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |